JNJ 38488502

Drug Profile

JNJ 38488502

Alternative Names: CR665; FE 200665

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ferring Pharmaceuticals; Freie Universitat Berlin
  • Developer ALZA Corporation
  • Class Anti-inflammatories; Opioid analgesics
  • Mechanism of Action Opioid kappa receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Postoperative pain

Most Recent Events

  • 10 Feb 2015 Cara Therapeutics has patent protection for κ opioid receptor agonists in USA
  • 19 Jun 2012 No development reported - Phase-I for Postoperative pain in United Kingdom (IV)
  • 19 Jun 2012 No development reported - Phase-II for Postoperative pain in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top